000			01699 a2200457 4500
005			20250516045730.0
264		0	_c20111003
008			201110s 0 0 eng d
022			_a1538-7445
024	7		_a10.1158/0008-5472.CAN-11-0277 _2doi
040			_aNLM _beng _cNLM
100	1		_aGilbert, Luke A
245	0	0	_aChemotherapeutic resistance: surviving stressful situations. _h[electronic resource]
260			_bCancer research _cAug 2011
300			_a5062-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Survival _xphysiology
650	0	4	_aDNA Damage _xphysiology
650	0	4	_aDNA, Neoplasm _xdrug effects
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm _xphysiology
650	0	4	_aEndothelial Cells _xmetabolism
650	0	4	_aHumans
650	0	4	_aInterleukin-6 _xmetabolism
650	0	4	_aLymphoma, B-Cell _xdrug therapy
650	0	4	_aMice
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasm, Residual
650	0	4	_aParacrine Communication _xphysiology
650	0	4	_aStromal Cells _xmetabolism
650	0	4	_aThymectomy
650	0	4	_aThymus Gland _xpathology
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism
650	0	4	_aTumor Microenvironment _xphysiology
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xphysiology
700	1		_aHemann, Michael T
773	0		_tCancer research _gvol. 71 _gno. 15 _gp. 5062-6
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-11-0277 _zAvailable from publisher's website
999			_c21019095 _d21019095